Table 6.
Suggested indications for SAPIEN XT and JenaValve in transapical approach
| SAPIEN XT™ | JenaValve™ | |
|---|---|---|
| Aortic annulus range | 18–27 | 21–27 |
| Straight ascending aorta | ≥65 mm | |
| Distance between annulus and coronary ostia | ≥10 mm | ≥8 mm |
| Bicuspid aortic valve | ++ | -- |
| Degenerated prosthesis | ++ | -- |
| Porcelain aorta | ++ | - |
| Severe calcified nodules on native leaflet | + | +/− |
| Non-calcified aortic valve (e.g. AR) | - | +++ |
| Small distance annulus to coronary ostia | +/− | ++ |
With the development of novel TAVI devices, a more tailored approach to device selection with regard to anatomical factors could be applied